1 Article by Akhil Anand
The therapeutic effects of psychedelics for opioid use disorder: A systematic review of clinical studies.
Psychiatry research – March 15, 2025
Summary
With opioid overdose deaths at alarming rates, exploring new treatments is crucial. Recent findings suggest psychedelics like ibogaine and ketamine may offer promise for opioid use disorder. While studies show potential benefits, many lack rigorous design. Future research could refine these therapies, including psilocybin and LSD, for better outcomes.
Abstract
Opioid-related overdose deaths have reached record high levels, and novel treatments for opioid use disorder (OUD) are needed. The three United Sta...